DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION

Marex Group Limited

NasdaqGS:MRX Stock Report

Market Cap: US$5.4b

  • Company Overview
    • Valuation
    • Future Growth
    • Past Performance
    • Financial Health
    • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

Marex Group Future Growth

Future criteria checks 2/6

Marex Group's revenue is forecast to decline at 3.6% per annum while its annual earnings are expected to grow at 15.8% per year. EPS is expected to grow by 13.1% per annum. Return on equity is forecast to be 24.1% in 3 years.

Key information

15.8%

Earnings growth rate

13.13%

EPS growth rate

Capital Markets earnings growth12.0%
Revenue growth rate-3.6%
Future return on equity24.14%
Analyst coverage

Good

Last updated14 Aug 2026

Recent future growth updates

Recent updates

User avatar
Narrative Update • Sep 03

MRX: Acquisition Momentum And Higher Margins Will Support Further Upside

Analysts have raised the Marex Group price target from $72.38 to $79.88, citing updated assumptions for a smaller revenue decline, a slightly higher profit margin, a modestly higher discount rate, and a slightly lower future P/E multiple. What’s in the News for Marex Group Marex Group reported Q2 2026 revenue of US$695.8 million, which was 39% higher year over year and more than 11% above analyst estimates.
User avatar
Narrative Update • Aug 20

MRX: Higher Profitability And Volatility-Driven Trading Volumes Will Support Upside

Marex Group's analyst fair value estimate has been revised from $75.00 to $100.00 as analysts factor in slightly higher assumed profit margins and a higher future P/E multiple, despite modestly softer projected revenue growth and a marginally higher discount rate. What’s in the News for Marex Group Marex Group reported Q2 2026 revenue of about US$696 million, up 39% year over year, with growth coming from all four business segments.
Seeking Alpha • Aug 17

Recent Results From Marex Group Impress, But Some Risks Are Rising

Summary Marex Group delivered record H1 2026 revenue and profitability, with adjusted profit before tax of $318.6 million, driving an 18% stock surge on August 12. MRX's rapid acquisition strategy fueled significant YoY segment revenue growth, notably 134% in Market Making and 35% in Agency and Execution. Operational efficiency improved: adjusted profit margin rose 200 bps to 23%, and adjusted ROE reached 37.5%, nearly 700 bps higher YoY. Despite valuation concerns and increased risk from acquisitions and debt, I maintain a Buy rating on MRX given sustained earnings momentum. Read the full article on Seeking Alpha
User avatar
Narrative Update • Aug 06

MRX: Rich Earnings Multiple Will Confront Weaker Revenue And Index Exclusion Risk

Analysts have raised their price target for Marex Group from about $37.00 to roughly $44.00, reflecting updated assumptions on fair value, discount rate, revenue growth, profit margin and future P/E. What's in the News Marex Group completed the acquisition of European equity derivatives market maker Webb Traders, which focuses on single stock options for European and US mid and large cap equities.
User avatar
Narrative Update • Jul 23

MRX: Bermuda Move And Digital Collateral Shift Will Constrain Upside Potential

Analysts have raised their price target for Marex Group from $59.75 to $72.38, citing updated assumptions around revenue contraction, profit margin, and future P/E that together support a higher fair value estimate. What’s in the News for Marex Group Marex Group is allowing derivatives clients to post USDC stablecoin as initial margin collateral using Coinbase infrastructure, following a December 2025 CFTC no action letter that permits futures commission merchants to accept certain digital assets as margin.
User avatar
Narrative Update • Jul 08

MRX: Bermuda Redomiciliation Will Limit Future Upside From Current Levels

Analysts have nudged their price target for Marex Group higher from $57.13 to $59.75, citing updated assumptions that combine slightly softer revenue expectations with a small improvement in projected profit margins and a modestly higher future P/E multiple. What’s in the News for Marex Group Marex Group Limited completed its redomiciliation from England and Wales to Bermuda on July 1, 2026, following shareholder approval on May 21, 2026, and English High Court sanction on June 26, 2026.
User avatar
Narrative Update • Jun 22

MRX: Higher Fair Value And Market Volatility Tailwinds Will Support Upside

Analysts have raised their price target for Marex Group from $66.00 to $75.00, citing updated assumptions around revenue trends, a slightly higher discount rate, and modestly adjusted profit margin and P/E expectations. What’s in the News for Marex Group Night Watch Investment Management identified Marex Group plc as its largest holding, highlighting the futures clearing business as critical financial infrastructure with a strong and defensible market position, and pointing to earnings that have grown roughly 7x over the past five years, according to recent commentary from the firm.
User avatar
Narrative Update • Jun 05

MRX: Levmet Deal And Bermuda Move Will Support Measured Future Upside

Analysts have maintained their $57.13 price target for Marex Group, reflecting steady assumptions for its discount rate, an expected revenue decline of 7.25%, a profit margin of 20.12% and a future P/E of 11.49x. What's in the News Marex Group agreed to acquire Levmet, a Monaco based liquidity provider focused on base and ferrous metals, energy, and power.
User avatar
Narrative Update • May 22

MRX: Q1 2026 Guidance And Dividend Outlook Will Support Measured Upside

Analysts have raised their price target for Marex Group from $55.00 to $57.13, citing updated assumptions on revenue trends, profit margins and future P/E expectations. What's in the News Marex Group plc issued earnings guidance for the first quarter of 2026, with expected revenue in a range of $667 million to $697 million for the period ended March 31, 2026, compared with Q1 2025 revenue of $467 million (Key Developments).
User avatar
Narrative Update • May 07

MRX: Higher Margins And Q1 2026 Outlook Will Support Measured Upside

Analysts have lifted Marex Group's price target from $50.29 to $55.00 as they now factor in a higher profit margin of about 20.9% and a lower future P/E of roughly 9.7, despite softer revenue growth assumptions and a slightly higher discount rate. What's in the News Marex Group issued earnings guidance for the first quarter ended March 31, 2026, with expected revenues in a range of $667 million to $697 million, compared with Q1 2025 revenues of $467 million (Key Developments).
User avatar
Narrative Update • Apr 22

MRX: Higher Fair Value And Lower Future P/E Will Support Upside

Analysts have lifted their fair value estimate for Marex Group from $61.00 to $66.00, citing updated assumptions for modest positive revenue growth, a slightly higher profit margin, and a lower future P/E of 11.40 compared with the prior 13.35. What's in the News Marex Group issued earnings guidance for the quarter ending March 31, 2026, with expected revenues in a range of $667 million to $697 million, compared with Q1 2025 revenues of $467 million (Key Developments).
User avatar
Narrative Update • Apr 07

MRX: Rich Earnings Multiple Will Face Test From Softer Revenue Outlook

Analysts have inched their price targets for Marex Group higher by a few dollars into the mid $40s, reflecting updated views on revenue trends, margins, and a lower forward P/E assumption in recent TD Cowen, Piper Sandler, and Barclays research. Analyst Commentary Recent research reflects a mixed tone, with some optimism on Marex Group's revenue and margin outlook, alongside more cautious views on where the shares should trade relative to sector peers.
User avatar
Narrative Update • Mar 24

MRX: Volatility And Trading Volumes Will Test Fairly Priced Shares

Analysts have lifted their average price target on Marex Group by mid single digits. Recent moves include $7 and $5 increases, citing updated assumptions for revenue trends, profit margins, and a lower implied future P/E multiple despite a slightly higher discount rate.
User avatar
Narrative Update • Mar 09

MRX: Higher Trading Volumes And Supportive P/E Will Drive Future Upside

Analysts have lifted their average price target on Marex Group to $61, citing updated views on revenue trajectory, profit margins, and a modestly higher future P/E multiple informed by recent Street research revisions from TD Cowen, Piper Sandler, and Barclays. Analyst Commentary Bullish analysts are leaning into Marex Group's execution by lifting their individual price targets, which helps explain the higher Street average.
User avatar
Narrative Update • Feb 23

MRX: Rising Trading Volumes And Volatility Will Support Earnings Power

Narrative update on Marex Group Analysts have nudged their Marex Group price targets higher by $7 and $5 in recent updates, while one cut a target by $1 to $49. These changes reflect adjusted views on volumes, volatility, and earnings potential rather than a change to our $61 fair value estimate.
User avatar
Narrative Update • Feb 07

MRX: Higher Volatility And Volumes Will Support Earnings Power Going Forward

The analyst price target for Marex Group has increased from $56 to $61, with analysts citing updated views on revenue trends, profit margins, and future P/E assumptions reflected in recent research from TD Cowen, Piper Sandler, and Barclays. Analyst Commentary Recent research updates show bullish analysts lifting their fair value estimates for Marex Group, with the latest round of work incorporating refreshed views on revenue trends, margin resilience, and P/E assumptions.
User avatar
Narrative Update • Jan 23

MRX: US Expansion And Higher Trading Volumes Will Support Future Upside

Analysts have raised their price targets on Marex Group, reflecting a revised fair value estimate from $47.71 to $50.29 as they factor in updated expectations around volumes, revenue trends, margins, and future P/E assumptions following recent sector research. Analyst Commentary Recent research updates on Marex Group show a mix of optimism and caution as analysts refresh their models ahead of upcoming results and sector comparisons.
User avatar
Narrative Update • Jan 08

MRX: Rising Trading Activity Will Support Earnings Power Despite Slight Price Trim

Analysts have trimmed their price target on Marex Group to US$49 from US$50, citing refreshed views on sector volumes and volatility while keeping fair value and key valuation inputs broadly unchanged. Analyst Commentary Bullish analysts are treating the lower US$49 price target as a fine tuning rather than a reset, keeping their broader view on Marex Group intact while they refresh assumptions for sector activity.
User avatar
Narrative Update • Dec 23

MRX Will Benefit From Expanding US Structured Products And Margin Resilience

Analysts have trimmed their price target on Marex Group by 4 percent to $56.00, citing slightly higher discount rates and weaker revenue growth expectations, partly offset by improved profit margin forecasts and a more attractive forward earnings multiple. What's in the News Marex Group launched a US structured products business targeting RIAs, broker dealers, and private banks.
User avatar
Narrative Update • Dec 09

MRX: US Expansion Will Drive Future Upside Despite Pending Securities Lawsuits

Narrative Update on Marex Group Price Target Analysts have modestly reduced their averaged price target on Marex Group from approximately $49.00 to about $47.70. This reflects slightly weaker top line growth assumptions, partially offset by expectations for improved profit margins and a marginally lower future price to earnings multiple.
User avatar
Narrative Update • Nov 25

MRX: Diversified US Expansion Will Drive Recovery Despite Securities Lawsuit Risk

Analysts have raised their price target for Marex Group from $47.67 to $49.00, citing updated assumptions around profit margins and discount rates, which support a modestly higher valuation. What's in the News Marex Group has launched its structured products business in the United States, led by Scott Kerbel.
User avatar
Narrative Update • Nov 06

MRX: Revenue Outlook Will Support Rebound Despite Ongoing Class Action Lawsuits

Analysts have made a minor upward adjustment to the price target for Marex Group, now set at $47.67. This change is based on slight improvements in the revenue growth outlook and a stable discount rate.
User avatar
Narrative Update • Oct 23

Analysts Lower Marex Group Price Target Amid Accounting Allegations and Revised Profit Outlook

Analysts have slightly lowered their price target for Marex Group from $49.33 to $47.67. This change reflects recent updates to the company’s growth and profitability outlook.
User avatar
Narrative Update • Oct 08

Digitalization And M&A Will Unlock Global Market Potential

Analysts have lowered their price target for Marex Group from $50.89 to $49.33, citing slightly reduced profit margin forecasts and modestly improved revenue growth projections. What's in the News NINGI Research disclosed a short position in Marex Group, alleging the company used opaque off-balance-sheet entities, fictitious transactions, and misleading disclosures to obscure losses and inflate profits (Periodical).
User avatar
New Narrative • Apr 27

Acquisitions Will Fuel APAC And Middle East Expansion

Strong market share gains and acquisition integration are driving revenue growth and expanding product offerings and geographic reach.

Earnings and Revenue Growth Forecasts

NasdaqGS:MRX - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20283,205581N/AN/A4
12/31/20272,849515N/A7717
12/31/20262,761469N/A2,7555
6/30/20263,489376419441N/A
3/31/20263,266334N/AN/AN/A
12/31/20252,870294648668N/A
9/30/20252,668266N/AN/AN/A
6/30/20252,6082511,6171,639N/A
3/31/20252,530234N/AN/AN/A
12/31/20242,3572051,1441,164N/A
9/30/20242,142189N/AN/AN/A
6/30/20241,883134N/AN/AN/A
3/31/20241,849140N/AN/AN/A
12/31/20231,882128723735N/A
9/30/20231,092140N/AN/AN/A
6/30/20231,818139N/AN/AN/A
3/31/20231,570115N/AN/AN/A
1/1/20231,01092216226N/A
1/1/202282557464471N/A
12/31/202075844-51-46N/A
12/31/201954936N/A-23N/A
12/31/201838410N/A130N/A
12/31/201731818N/A-96N/A
12/31/201632820N/A30N/A
12/31/201534618N/A8N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: MRX's forecast earnings growth (15.8% per year) is above the savings rate (3.7%).

Earnings vs Market: MRX's earnings (15.8% per year) are forecast to grow slower than the US market (17.4% per year).

High Growth Earnings: MRX's earnings are forecast to grow, but not significantly.

Revenue vs Market: MRX's revenue is expected to decline over the next 3 years (-3.6% per year).

High Growth Revenue: MRX's revenue is forecast to decline over the next 3 years (-3.6% per year).


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: MRX's Return on Equity is forecast to be high in 3 years time (24.1%)


Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/20 01:12
End of Day Share Price 2026/09/18 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Marex Group Limited is covered by 12 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Benjamin BudishBarclays
"Benjamin BudishBarclays
Christopher AllenCitigroup Inc

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide